![](/img/cover-not-exists.png)
PCN244 BUDGETARY IMPACT OF VENETOCLAX WITH RITUXIMAB VERSUS IBRUTINIB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Brito Filho, C., Vitale, V., Vieira, F.M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.439
Date:
November, 2019
File:
PDF, 381 KB
2019